Source: Eur Respir J 2016; 47: 1040-1042
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Reber Laurent L., Fahy John V.. Mast cells in asthma: biomarker and therapeutic target. Eur Respir J 2016; 47: 1040-1042

Member's Comments

No comment yet.

Related content which might interest you: Can YKL-40 be used as a biomarker and therapeutic target for adult asthma? Source: Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017 Year: 2018 Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations Source: Eur Respir J, 50 (4) 1602434; 10.1183/13993003.02434-2016 Year: 2017 Mast cells in lung disease: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease Source: Eur Respir J 2007; 30: 383-390 Year: 2007 Airway inflammation in asthma: current and future targets and therapies Source: Breathe 2010; 6: 245-252 Year: 2010 Mast cells and eosinophils: the two key effector cells in allergic inflammation Source: Annual Congress 2010 - Mast cells and eosinophils: the two key effector cells in allergic inflammation Year: 2010 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies Year: 2009 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009 Novel sub-classifications of mast cells in human lungs: differential alterations in smokers and COPD Source: Annual Congress 2007 - Advances in respiratory mechanics Year: 2007 Neovascularisation in asthma: Altered angiogenic potential of ASM cells from asthmatic patients Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 TSPO a new anti-inflammatory target in the airway of COPD Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Therapeutic potential of mesenchymal stem cells modified to secrete anti-inflammatory protein sST2 in a model of occupational asthma Source: Annual Congress 2012 - Occupational asthma Year: 2012 Mast cells in human airways: the culprit? Source: Eur Respir Rev 2014; 23: 299-307 Year: 2014 Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015